AstraZeneca's Calquence gains FDA nod for 1L MCL treatment By Investing.com

Published on 17 Jan 2025 on Investing.com

Today, AstraZeneca PLC (LSE/STO/Nasdaq: LON:AZN), a pharmaceutical giant with a market...

Read the rest of the article

Start tracking your investments with Statfolio

We recently compiled a list of the 15 Best Large-Cap Value Stocks to Buy in 2025. In this article...

Insider Monkey · via Yahoo Finance 22 Jan 2025

The FDA's nod is based on late-stage data, which show AZN's Datroway cuts the risk of disease...

Zacks · via Yahoo Finance 20 Jan 2025

This investing style is all about taking advantage of upward or downward trends in a stock's pric...

Zacks · via Yahoo Finance 20 Jan 2025

Today, AstraZeneca PLC (LSE/STO/Nasdaq: LON:AZN), a pharmaceutical giant with a market...

Investing.com 17 Jan 2025

Dividend stocks trading at discounted prices can make for great investments if you're willing to ...

Motley Fool · via Yahoo Finance 15 Jan 2025

We recently published a list of Billionaire George Soros Stock Portfolio: Top 10 Stock Picks. In...

Insider Monkey · via Yahoo Finance 14 Jan 2025

For long-term investors, now may be a good time to reevaluate the contents of your portfolio to s...

Motley Fool · via Yahoo Finance 9 Jan 2025

We recently compiled a list of the 10 Best FTSE Dividend Stocks To Buy Now. In this article, we a...

Insider Monkey · via Yahoo Finance 6 Jan 2025

Sweden shares lower at close of trade; OMX Stockholm 30 down 0.28%

Investing.com 31 Dec 2024

Monday, H.C. Wainwright began covering Emergent BioSolutions Inc. (NYSE:EBS) with a Buy rating an...

Investing.com 30 Dec 2024